Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases.

× No keyword cloud information.

28 in total

1. Periosteal grafting for congenital pseudarthrosis of the tibia: a preliminary report.

Authors: Ahmed M Thabet; Dror Paley; Mehmet Kocaoglu; Levent Eralp; John E Herzenberg; Omer Naci Ergin
Journal: Clin Orthop Relat Res Date: 2008-10-25 Impact factor: 4.176

2. Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: A retrospective study with a minimum 2-year follow-up.

Authors: Tim N Hissnauer; Norbert Stiel; Kornelia Babin; Martin Rupprecht; Michael Hoffmann; Johannes M Rueger; Ralf Stuecker; Alexander S Spiro
Journal: J Mater Sci Mater Med Date: 2017-02-17 Impact factor: 3.896

3. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.

Authors: Jean de la Croix Ndong; David M Stevens; Guillaume Vignaux; Sasidhar Uppuganti; Daniel S Perrien; Xiangli Yang; Jeffry S Nyman; Eva Harth; Florent Elefteriou
Journal: J Bone Miner Res Date: 2015-01 Impact factor: 6.741

4. Vascularised fibular graft for the treatment of congenital pseudarthrosis of the tibia: long-term complications in the donor leg.

Authors: Raquel B Iamaguchi; Patricia M M B Fucs; Antonio Carlos da Costa; Ivan Chakkour
Journal: Int Orthop Date: 2010-08-01 Impact factor: 3.075

5. Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.

Authors: Oliver Birke; Aaron Schindeler; Manoj Ramachandran; Chris T Cowell; Craig F Munns; Michael Bellemore; David G Little
Journal: J Child Orthop Date: 2010-10-21 Impact factor: 1.548

Review 6. Ilizarov treatment of congenital pseudarthrosis of the tibia: a multi-targeted approach using the Ilizarov technique.

Authors: In Ho Choi; Tae-Joon Cho; Hyuk Ju Moon
Journal: Clin Orthop Surg Date: 2011-02-15

Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases.

1. Periosteal grafting for congenital pseudarthrosis of the tibia: a preliminary report.

2. Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: A retrospective study with a minimum 2-year follow-up.

3. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.

4. Vascularised fibular graft for the treatment of congenital pseudarthrosis of the tibia: long-term complications in the donor leg.

5. Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.

Review 6. Ilizarov treatment of congenital pseudarthrosis of the tibia: a multi-targeted approach using the Ilizarov technique.

7. Successful treatment of congenital pseudarthrosis of the tibia: still a challenge.

8. The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.

9. Congenital pseudarthrosis of the tibia: the results of an evolving protocol of management.

10. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report.